Atlas Wealth LLC Sells 2,267 Shares of CVS Health Co. (NYSE:CVS)

Atlas Wealth LLC trimmed its holdings in shares of CVS Health Co. (NYSE:CVS) by 41.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,232 shares of the pharmacy operator’s stock after selling 2,267 shares during the quarter. Atlas Wealth LLC’s holdings in CVS Health were worth $203,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Atom Investors LP bought a new position in shares of CVS Health during the 3rd quarter worth approximately $1,273,000. TOMS Capital Investment Management LP acquired a new stake in CVS Health in the third quarter worth $121,987,000. Kestra Investment Management LLC bought a new stake in CVS Health in the third quarter valued at $341,000. B&L Asset Management LLC acquired a new position in shares of CVS Health during the third quarter valued at about $204,000. Finally, Erste Asset Management GmbH bought a new position in shares of CVS Health during the 3rd quarter worth about $6,109,000. 80.66% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the stock. Piper Sandler cut their price objective on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research report on Monday, November 25th. Evercore ISI increased their price objective on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. UBS Group increased their price objective on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research report on Thursday, November 7th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a research note on Tuesday, October 1st. Finally, StockNews.com lowered shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $70.33.

CVS Health Price Performance

NYSE CVS opened at $59.85 on Monday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 52 week low of $52.71 and a 52 week high of $83.25. The company has a market cap of $75.32 billion, a PE ratio of 15.19, a price-to-earnings-growth ratio of 1.02 and a beta of 0.55. The firm’s 50-day simple moving average is $59.36 and its two-hundred day simple moving average is $58.77.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.21 earnings per share. Research analysts predict that CVS Health Co. will post 5.37 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.44%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.